Jordan Gauthier

Hematology
825 Eastlake Ave E
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications

Coordinated expansion of CD163⁺ monocytes and immature CD177⁺ neutrophils marks severe neurotoxicity after CD19 CAR T cell therapy.

Coordinated expansion of CD163⁺ monocytes and immature CD177⁺ neutrophils marks severe neurotoxicity after CD19 CAR T cell therapy.

Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026

Erratum: Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration.

Erratum: Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration.

Journal: JCO clinical cancer informatics
Published: April 20, 2026

Early neurologic response predicts outcomes after anakinra for immune effector cell-associated neurotoxicity syndrome.

Early neurologic response predicts outcomes after anakinra for immune effector cell-associated neurotoxicity syndrome.

Journal: Blood advances
Published: February 18, 2026

Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.

Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004.

Journal: Blood
Published: February 05, 2026

Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration.

Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration.

Journal: JCO clinical cancer informatics
Published: January 30, 2026

Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models.

Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based Models.

Journal: JCO clinical cancer informatics
Published: January 14, 2026

Fear of Cancer Recurrence in Hematopoietic Cell Transplantation Survivors.

Fear of Cancer Recurrence in Hematopoietic Cell Transplantation Survivors.

Journal: Transplantation and cellular therapy
Published: January 14, 2026

Expert Panel Review and Practical Guidance on Biomarker Testing with Engineered Immune Effector Cells.

Expert Panel Review and Practical Guidance on Biomarker Testing with Engineered Immune Effector Cells.

Journal: Transplantation and cellular therapy
Published: January 05, 2026

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Journal: Haematologica
Published: December 19, 2025

Novel antibodies for identification, selection, and manipulation of T cells expressing Whitlow linker-containing CARs.

Novel antibodies for identification, selection, and manipulation of T cells expressing Whitlow linker-containing CARs.

Journal: Journal for immunotherapy of cancer
Published: October 28, 2025

Prior transplantation and idecabtagene vicleucel in multiple myeloma: a secondary analysis of CIBMTR data.

Prior transplantation and idecabtagene vicleucel in multiple myeloma: a secondary analysis of CIBMTR data.

Journal: Blood
Published: August 29, 2025

Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response.

Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response.

Journal: Nature communications
Published: July 14, 2025
Showing 1-12 of 102

Last Updated: 09/26/2026